Ezetimibe (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Ezetimibe drug offered from Actavis Pharma, Inc.. This Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Ezetimibe |
| SUBSTANCE NAME: | EZETIMIBE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-06-12 |
| END MARKETING DATE: | 0000-00-00 |
Ezetimibe HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ezetimibe from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2017-06-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-3713_8e147856-b3b4-44e9-bbf4-43d67f86e42c |
| PRODUCT NDC: | 0591-3713 |
| APPLICATION NUMBER: | ANDA200831 |
Other EZETIMIBE Pharmaceutical Manufacturers / Labelers:
